Enhanced apoptotic action of trichosanthin in HIV-1 infected cells

Biochemical and Biophysical Research Communications

Volumn 331, Issue 4, 2005, Pages 1075-1080

  Wang, Yuan Yuan ^a,c   Ouyang, Dong Yun ^a,c   Huang, Hai ^b   Chan, Herman ^b   Tam, Siu Cheung ^b   Zheng, Yong Tang ^a  

^a KUNMING INSTITUTE OF ZOOLOGY   (China)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

Anti HIV activity; Apoptosis; HIV 1; Infected cells; Trichosanthin

Indexed keywords

ANTIVIRUS AGENT; DNA FRAGMENT; TRICHOSANTHIN;

ANTIVIRAL ACTIVITY; APOPTOSIS; ARTICLE; CELL POPULATION; CELL VIABILITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; PROTEIN FUNCTION;

APOPTOSIS; CELL LINE; FLOW CYTOMETRY; HIV-1; HUMANS; TRICHOSANTHIN;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 18844433032     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2005.03.230     Document Type: Article

References (25)

1. J.S. Zhang, and W.Y. Liu The mechanism of action of trichosanthin on eukaryotic ribosomes-RNA N-glycosidase activity of the cytotoxin Nucleic Acids Res. 20 1992 1271 1275
2. M.S. McGrath, S. Santulli, and I. Gaston Effects of GLQ223 on HIV replication in human monocyte/macrophages chronically infected in vitro with HIV AIDS Res. Hum. Retroviruses 6 1990 1039 1043
3. M.S. McGrath, K.M. Hwang, S.E. Caldwell, I. Gaston, K.C. Luk, P. Wu, V.L. Ng, S. Crowe, J. Daniels, J. Marsh, T. Deinhart, P.V. Lekas, J.C. Vennari, H.W. Yeung, and J.D. Lifson GLQ223: an inhibitor of human immunodeficiency virus replication in acutely and chronically infected cells of lymphocyte and mononuclear phagocyte lineage Proc. Natl. Acad. Sci. USA 86 1989 2844 2848
4. J.H. Wang, H.L. Nie, S.C. Tam, H. Huang, and Y.T. Zheng Anti-HIV-1 property of trichosanthin correlates with its ribosome inactivating activity FEBS Lett. 531 2002 295 298
5. J.H. Wang, H.L. Nie, H. Huang, S.C. Tam, and Y.T. Zheng Independency of anti-HIV-1 activity from ribosome-inactivating activity of trichosanthin Biochem. Biophys. Res. Commun. 302 2003 89 94
6. J.O. Kahn, K.J. Gorelick, G. Gatti, C.J. Arri, J.D. Lifson, J.G. Gambertoglio, A. Bostrom, and R. Williams Safety, activity, and pharmacokinetics of GLQ223 in patients with AIDS and AIDS-related complex Antimicrob. Agents Chemother. 38 1994 260 267
7. V.S. Byers, A.S. Levin, A. Malvino, L. Waites, R.A. Robins, and R.W. Baldwin A phase II study of effect of addition of trichosanthin to zidovudine in patients with HIV disease and failing antiretroviral agents AIDS Res. Hum. Retroviruses 10 1994 413 420
8. V.S. Byers, A.S. Levin, L.A. Waites, B.A. Starrett, R.A. Mayer, J.A. Clegg, M.R. Price, R.A. Robins, M. Delaney, and R.W. Baldwin Phase I/II study of trichosanthin treatment of HIV disease AIDS 4 1990 1189 1196
9. W.L. Chan, P.C. Shaw, X.B. Li, Q.F. Xu, X.H. He, and S.C. Tam Lowering of trichosanthin immunogenicity by site-specific coupling to dextran Biochem. Pharmacol. 57 1999 927 934
10. X.H. He, P.C. Shaw, L.H. Xu, and S.C. Tam Site-directed polyethylene glycol modification of trichosanthin: effects on its biological activities, pharmacokinetics, and antigenicity Life Sci. 64 1999 1163 1175
11. X.H. He, P.C. Shaw, and S.C. Tam Reducing the immunogenicity and improving the in vivo activity of trichosanthin by site-directed pegylation Life Sci. 65 1999 355 368
12. Y.T. Zheng, W.L. Chan, P. Chan, H. Huang, and S.C. Tam Enhancement of the anti-herpetic effect of trichosanthin by acyclovir and interferon FEBS Lett. 496 2001 139 142
13. F. Stirpe, and L. Barbieri Ribosome-inactivating proteins up to date FEBS Lett. 195 1986 1 8
14. A.J. Vlietinck, T.D. Bruyne, S. Apers, and L.A. Pieters Plant-derived leading compounds for chemotherapy of human immunodeficiency virus (HIV) infection Planta Med. 64 1998 97 109
15. C. DeLuca, H. Kwon, N. Pelletier, M.A. Wainberg, and J. Hiscott NF-kB protects HIV-1-Infected myeloid cells from apoptosis Virology 244 1998 27 38
16. R. Geleziunas, W. Xu, K. Takeda, H. Ichijo, and W.C. Greene HIV-1 Nef inhibits ASK1-dependent death signalling providing a potential mechanism for protecting the infected host cell Nature 410 2001 834 838
17. S. Gartner, and M. Popovic Virus isolation and production A. Aldovini B.D. Walker Techniques in HIV research 1990 Stockton New York 53 69
18. K. Noguchi, M. Naito, S. Kataoka, S. Yonehara, and T. Tsuruo A recessive mutant of the U937 cell line acquired resistance to anti-Fas and anti-p55 tumor necrosis factor receptor antibody-induced apoptosis Cell Growth Differ. 6 1995 1271 1277
19. C. Cartier, M. Deckert, C. Grangeasse, R. Trauger, F. Jensen, A. Bernard, A. Cozzone, C. Desgranges, and V. Boyer Association of ERK2 mitogen-activated protein kinase with human immunodeficiency virus particles J. Virol. 71 1997 4832 4837
20. J.M. Jacque, A. Mann, H. Enslen, N. Sharova, B. Brichacek, R.J. Davis, and M. Stevenson Modulation of HIV-1 infectivity by MAPK, a virion-associated kinase EMBO J. 17 1998 2607 2618
21. L. Shapiro, K.A. Heidenreich, M.K. Meintzer, and C.A. Dinarello Role of p38 mitogen-activated protein kinase in HIV type 1 production in vitro Proc. Natl. Acad. Sci. USA 95 1998 7422 7426
22. X. Yang, and D. Gabuzda Regulation of human immunodeficiency virus type 1 infectivity by the ERK mitogen-activated protein kinase signalling pathway J. Virol. 73 1999 3460 3466
23. G.J. Teltow, J.D. Irvin, and G.M. Aron Inhibition of herpes simplex virus DNA synthesis by pokeweed antiviral protein Antimicrob. Agents Chemother. 23 1983 390 396
24. S. Aquaro, P. Bagnarelli, T. Guenci, A. De Luca, M. Clementi, E. Balestra, R. Calio, and C.F. Perno Long-term survival and virus production in human primary macrophages infected by human immunodeficiency virus J. Med. Virol. 68 2002 479 488
25. F. Ensoli, V. Fiorelli, C. Alario, M. De Cristofaro, D. Santini Muratori, A. Novi, M.G. Cunsolo, F. Mazzetta, A. Giovannetti, B. Mollicone, E. Pinter, and F. Aiuti Decreased T cell apoptosis and T cell recovery during highly active antiretroviral therapy (HAART) Clin. Immunol. 97 2000 9 20